As practices across the country continue to adopt non-invasive hydrogen and methane breath testing to improve diagnostic accuracy for functional gastrointestinal conditions, one performance metric is proving especially critical to clinical and operational success: the test return ratio.
The short answer
Return ratio is the percentage of breath test kits sent out that come back completed, interpretable, and analyzed. It is a direct measure of patient follow-through and process efficiency, and the clearest single indicator of whether your breath testing program is producing clinical value. Top-performing practices in CDI’s national network exceed 70%. Most groups do not know their number at all.
The calculation
Measured over a defined period, at the group, site, or provider level.
Breath Testing Done Right — 45 pages on clinical integrity, protocol, operations, and economic yield.
Why return ratio matters
Each breath test represents a potential diagnosis, a treatment decision, and a better outcome for your patient. When kits go unregistered or unreturned, it isn’t just a logistical issue. It’s a missed opportunity for care.
Think about a typical month. You identify the patients who need testing. You or your staff order and distribute kits. You expect those kits to come back, be analyzed, and inform next steps. If only six out of ten make it all the way through, you are losing value on three levels at once:
- Clinical: four patients never get the data you intended to use
- Operational: the staff time spent explaining and distributing kits never translates into action
- Economic: the professional revenue from those interpretations goes uncaptured
Low return ratios also burden clinical staff with administrative follow-up, delay treatment planning, and skew practice-level data when evaluating test utilization and patient engagement. Practices with high return ratios typically see:
- More actionable diagnostic results
- Higher provider satisfaction and confidence in testing
- Faster patient follow-up and better continuity of care
- Greater operational efficiency and reimbursement alignment
What return ratio reveals that volume doesn’t
Many GI groups track breath testing by kits ordered or tests billed. Both matter, but both can hide a lot. Consider two providers who each order 100 kits per quarter. On volume alone, they look identical.
Same volume, different outcome
100 kits each. Only one is producing results.
85 completed tests — 15 kits never produced usable data
55 completed tests — 45 kits never produced usable data
Add return ratio and the difference becomes a conversation you can actually have — about workflow, patient population, or the support each provider’s patients are getting. You cannot have that conversation without a clear view of the number.
Where return ratio breaks down
Kits are rarely lost in one dramatic failure. They leak out at four distinct points, and each one calls for a different fix.
Four leak points
Where kits stop becoming results
The kit leaves the clinic but is never tied to a patient you or the lab can see.
The patient intends to test but feels unsure about prep, gets busy, or loses the kit.
Collection happened, but the sample was forgotten, misdropped, or hit a shipping barrier.
Collection error, timing problem, or sample integrity issue means no interpretable data.
The distinction matters. A practice losing kits at the handoff needs a registration fix. A practice losing them at analysis needs a prep and protocol fix. Both show up as the same low number until you separate them.
How to calculate your return ratio
You don’t need perfect data to start. Even a first-pass estimate is usually eye-opening.
-
Pick a closed quarter
Use a period far enough back that kits have had time to come home. A recent quarter will understate your ratio.
-
Count kits ordered or distributed in that period
This is your denominator. Shipped to the practice, shipped to patients, or both.
-
Count completed, interpretable results received
This is your numerator. Interpretable is the operative word — a returned sample that couldn’t be read doesn’t count.
-
Divide, and write the number down
84 completed from 120 distributed is a 70% return ratio. That is your baseline.
Refine it over time by excluding out-of-period returns, segmenting by provider and site, and separating “returned but unusable” from “never returned.” The goal isn’t a mathematically perfect figure on day one. It’s a baseline you can improve from.
Two full chapters on return ratio, registration, and the cost of unreturned kits.
What good looks like
Across CDI’s national network of healthcare providers, top-performing practices achieve a return ratio of over 70%. Broadly, performance falls into three bands.
Benchmarking your number
Where at-home breath testing programs typically land
Many patients never complete the intended test. Look first at registration, patient support, and logistics.
Solid, especially in complex or geographically dispersed populations. Still meaningful room to improve yield.
Indicates robust processes, real patient support, and deliberate program design.
What drives return ratio
Four levers account for most of the variation between practices.
Kit registration compliance
Practices that consistently register kits — or ensure that patients do — see significantly higher test completion rates. Breath test kit registration is the control point that makes everything downstream visible. It enables proactive support from CDI’s patient services team, including automated reminders, educational resources, and troubleshooting. An unregistered kit is invisible to everyone.
Direct-to-patient outreach
For kits shipped directly to patients, including complete and accurate contact information — especially email and phone — with the provider order form enables CDI to engage patients promptly, which increases the likelihood of follow-through.
Workflow integration
Practices that establish a standard operating procedure see fewer missed registrations. Having the patient complete kit registration at the point of handoff, and returning the provider portion of the kit requisition form to CDI, creates accountability in the handoff rather than hoping it happens later.
Patient education and expectations
Clear communication about how and when to complete the test, and about why the result matters to their care plan, significantly improves compliance. Sixty seconds of framing at the handoff is one of the highest-yield interventions available to a practice.
What every unreturned kit actually costs
The clearest way to see the value of return ratio is to hold volume constant and move only the completion rate.
Same 600 kits
A 20-point gain is 120 more patients with actionable data
Base: 600 kits distributed per year. No additional kits ordered.
Behind that gap sit three real costs. Clinically, each uncompleted kit is a care plan that stalls — a follow-up visit spent explaining that the test was never done rather than acting on a result. Operationally, the visit time, inventory, prep questions, and follow-up calls were all spent whether or not the kit came back. Economically, each uncompleted kit is a foregone professional interpretation. Across a medium or large GI group, that is hundreds of missed billable events per year.
Cost clarity is part of completion
There is a patient-side dimension too. When out-of-pocket costs are unclear or vary widely, some patients quietly delay or abandon testing without ever telling the practice. A predictable affordability story — a maximum $299 out-of-pocket cap on breath tests, and Medicare fully covered with no balance billing — removes one of the quieter reasons kits never come back.
Return ratio and turnaround work together
Return ratio determines how many tests make it through the pathway. Turnaround time determines how quickly those results can move care forward. Results delivered within 1 business day of sample receipt make it far easier to align follow-up visits with fresh data, avoid holding-pattern appointments, and maintain patient confidence that the test was worth the effort. Improve both and breath testing stops being a bottleneck.
How CDI helps
MyGI Gateway, CDI’s secure provider platform, gives practices real-time visibility into every test shipped and returned. Practices can monitor compliance, track kit registration status, and follow the full test lifecycle from order to result. CDI’s dedicated Provider Relations Specialists are available to review your metrics and help optimize workflows tailored to your staff and patient population.
With rising demand for efficient, value-based diagnostics, maintaining a strong return ratio is no longer just an operational detail. It is a core driver of clinical quality. CDI remains committed to supporting our partners in achieving the highest standards in breath testing utilization and patient-centered care.
Where to start this quarter
-
Baseline your number
Estimate return ratio for one closed quarter, even roughly. You cannot improve what you have never measured.
-
Find your dominant leak point
Registration, prep, return, or analysis. Fixing the wrong one costs a quarter.
-
Change one thing
For most groups, moving registration to the moment the kit is handed to the patient is the highest-yield single change.
-
Set a concrete target
A 10-point gain over two quarters is realistic for most programs and easy to defend to leadership.
-
Recheck and share the story
“We distributed X, Y became results, here is what that meant for patients and for us” is the sentence that changes staff behavior.
If you’d like a structured view across your whole program rather than this one metric, the Breath Testing Program Self-Assessment takes 10–15 minutes and covers clinical integrity, protocol integrity, operational performance, and economic yield.
Return ratio FAQs
What is return ratio in breath testing?
Return ratio is the percentage of breath test kits sent out — to a practice or directly to patients — that are completed, returned, and successfully analyzed. It is a direct measure of patient follow-through and process efficiency, and a strong indicator of a breath testing program’s clinical impact.
How do I calculate my practice’s return ratio?
Divide the number of completed, interpretable results received by the number of kits distributed in the same period. For example, 84 completed tests from 120 distributed kits is a 70% return ratio. Use a closed quarter rather than a recent one, so kits have had time to come back.
What is a good return ratio for breath testing?
Top-performing practices in CDI’s national network achieve over 70%. Below 60% generally signals substantial leakage worth investigating. Between 70% and 80% is reasonable performance, especially in complex or geographically dispersed patient populations. Above 80% indicates strong processes and deliberate program design.
Why do breath test kits go unreturned?
Kits are typically lost at one of four points: the kit is never registered to a patient, the patient never completes prep or collection, the completed sample is never mailed back, or the returned sample is unusable because of a collection, timing, or integrity problem. Each requires a different fix, which is why identifying the dominant leak point matters more than the overall number.
How does kit registration affect return ratio?
Registration is the control point that makes everything downstream visible. A registered kit can trigger reminders, patient education, and troubleshooting support, and it lets the practice see exactly where each test stands. An unregistered kit is invisible to both the practice and the lab, so it can neither be supported nor counted.
What is a 10-point improvement in return ratio worth?
It depends on volume, but the math is straightforward. Across 600 kits a year, moving from 60% to 80% produces 120 additional completed tests — 120 more patients with actionable data, and 120 more billable professional interpretations, without ordering a single extra kit.
Does return ratio differ between ship-to-practice and ship-to-patient?
Less than most practices expect. The bigger determinants are whether kits are registered, how clearly patients are prepared, and whether anyone follows up. Fulfillment model matters mainly because it changes who is responsible for registration and patient contact information.
How can CDI help us improve our return ratio?
MyGI Gateway gives real-time visibility into every kit shipped, registered, returned, and resulted. CDI’s Provider Relations Specialists review your metrics with you and recommend workflow changes tailored to your staff and patient population, usually starting with one or two changes rather than a full redesign.
Breath Testing Done Right
Make every shipped kit count
Forty-five pages on clinical integrity, protocol, operational performance, and economic yield — including two full chapters on return ratio and the real cost of unreturned kits.
